L'Ontario investit 1,7 million de dollars pour stimuler l'innovation dans le domaine des sciences de la vie au site d'Aurora de Piramal Pharma

Positive

AI Analysis

Summary

Piramal Pharma Solutions is investing over $5.3 million to modernize its Aurora active pharmaceutical ingredients manufacturing site, with Ontario providing $1.7 million in support through the Life Sciences Scale-Up Fund.

Importance:3/10

Sentiment:

0.60

capital_investmentinfrastructuremanufacturingCanadalife_sciences

Read the original article

Published by PR Newswire Pharma on September 30, 2026 7:30 PM

Read Original